<h4>Purpose</h4>The relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and acromegaly is unclear due to the complex metabolic effects of growth hormone (GH). This evidence concerns the gene GH1 and metabolic dysfunction-associated steatotic liver disease.